Comparative performance of the Siemens Atellica and Abbott Architect assays for HBsAg quantification in patients with chronic hepatitis B or hepatitis Delta

20260 citationsJournal Articlehybrid Open Access

Authors

The Atellica assay demonstrated equivalent performance to the Architect assay for qHBsAg monitoring in patients with CHB or CHD.

Good health and well-being

Published in: Journal of Clinical Virology

Volume 182, pp. 105913-105913

Field-Weighted Citation Impact: 0.00